Improving the Delivery of Brain Health Care to All. Keeping our Eye on the Main Prize in an Era of Emerging Anti-Amyloid Therapies
Manuel Montero-Odasso, Linda Lee, David B. Hogan · 2026
Read Improving the Delivery of Brain Health Care to All. Keeping our Eye on the Main Prize in an Era of Emerging Anti-Amyloid Therapies by Manuel Montero-Odasso, Linda Lee, David B. Hogan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13215368.txt.
Description
Manuel Montero-Odasso, Linda Lee, and David B. Hogan argue in 2026 that new anti-amyloid drugs for Alzheimer's disease must not swallow the whole brain-health agenda in Canada. The injected drugs help modestly, suit few patients, and cost a great deal.
Only a small minority of memory clinic patients meet the strict eligibility rules, and public funding decisions in Canada are still pending after one drug's conditional approval. Safe delivery demands scanning, genetic checks, and monitoring infrastructure. Meanwhile most patients and families need diagnosis, risk reduction, symptom care, and support today. Keeping eyes on that main prize, the authors say, is how scarce money serves everyone with cognitive concerns.
Catalog record
| CREATOR | Manuel Montero-Odasso, Linda Lee, David B. Hogan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |